Dolutegravir Plus Tenofovir/Lamivudine or Emtricitabine in HIV-1 Infected Transgender Women
NCT03033836
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
60
Enrollment
OTHER
Sponsor class
Conditions
HIV Infections
Interventions
DRUG:
ARV treatment
Sponsor
Fundación Huésped
Collaborators
[object Object]